S
Surrozen D
D
SRZN
9.08000
USD
-0.83
(-8.38%)
Market Closed
Volume
320
EPS
0
Div Yield
0
P/E
-0
Market Cap
29,109,136
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Surrozen
Sector: Healthcare
Industry: Biotechnology
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).